Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011854 (
type 1 diabetes
)
20,749
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recent evidence indicates that
immunoglobulin light chain variable region
genes are genetic determinants for Graves' disease, which is caused by autoantibodies which stimulate the thyroid gland. We have tested whether germline immunoglobulin kappa light chain variable region (V kappa) genes contribute to the genetic predisposition for
IDDM
. Status for the kappa light chain constant region (C kappa) allotype, Km(1), was determined in members of suitable multiplex
IDDM
families. Such families had two or more siblings with
IDDM
, together with one parent negative for Km(1) and the other heterozygous, so that each sibling had a 50% chance of receiving the kappa light chain marker. Twenty-one families of this type were found. Of the siblings, disregarding disease status, 31 were concordant with the diabetic proband for Km(1) and 29 were discordant, this close approximation to equality confirming the validity of the methodology. Of the diabetic siblings of the probands, 14 were concordant and 15 discordant. Of the non-diabetic siblings, 17 were concordant and 14 discordant. This similarity shows that V kappa genes, which are closely linked to C kappa genes, are not genetic determinants for
IDDM
. The contrast with Graves' disease favours the possibility that the islet beta cell destruction of
IDDM
is mediated by forbidden clones of cytotoxic T cells, rather than of B cells.
...
PMID:Genetic evidence favouring cytotoxic T cell forbidden clones as the cause of insulin-dependent diabetes mellitus. 297 6